Safeguarding the future of biomedical science in the United States.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40023153.
- Also identified by DOI 10.1016/j.cell.2025.02.024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
NIH's abrupt decision to cap indirect cost reimbursement at 15% threatens the critical infrastructure supporting groundbreaking biomedical research in the United States. This policy jeopardizes America's global leadership in science and medicine. Urgent action is needed to advocate for its immediate and permanent reversal to protect the future of science.
Medical subject headings
- Biomedical Research